|
VOLUME 33: NO. 11 NOVEMBER 2006
Editorials
Citrullinated Antigens: Just Diagnostic Tools or Pathogenic Targets in Rheumatoid Arthritis?
 E. Feist, G.R. Burmester.........2103
Cardiovascular Risk in Inflammatory Rheumatic Diseases: Loose Ends and Common Threads
 T.M. Farragher, I.N. Bruce.........2105
Improving Management of Pregnancy in Antiphospholipid Antibody-Positive Women
 M. Galli.........2108
Remember the Titanic: What We Know of Knee Osteoarthritis Is But the Tip of the Iceberg
 A.E. Wluka.........2110
The Symptom Intensity Scale, Fibromyalgia, and the Meaning of Fibromyalgia-like Symptoms. A Review
 H. Smythe.........2113
Articles
Serum Autoantibodies that Bind Citrullinated Fibrinogen Are Frequently Found in Patients with RA
 J.A. Hill, J. Al-Bishri, D.D. Gladman, E. Cairns,
D.A. Bell .........2115
HLA-DRB1*04 Alleles in Japanese RA Patients with AA Amyloidosis
 K. Migita, T. Nakamura, Y. Maeda, et al.........2120
Cost-Effectiveness of Biologic Agents for Treatment of Autoimmune Disorders: Structured Review of the Literature
 R. Fleurence, E. Spackman.........2124
Declining Trend in the Incidence of RF-Positive
RA in Finland 1980-2000
 O. Kaipiainen-Seppanen, H. Kautiainen.........2132
Association of RA with Ergothioneine Levels
in RBC: A Case Control Study
 D. Taubert, A. Lazar, G. Grimberg, et al.........2139
An Index of Patient-Reported Outcomes
(PRO-Index) Discriminates Effectively Between
Active and Control Treatment in 4 Clinical Trials of Adalimumab in RA
 T. Pincus, C. Chung,
O.G. Segurado, I. Amara, G.G. Koch.........2146
Comparison of Tacrolimus and Mizoribine in a Randomized, Double-blind Controlled Study in Patients with RA
 S. Kawai, H. Hashimoto, H. Kondo,
T. Murayama, T. Kiuchi, T. Abe.........2153
Reduction of Inflammatory Biomarker Response by Abatacept in Treatment of RA
 M.H. Weisman, P. Durez, D. Hallegua, et al .........2162
CVD and Risk Factors in Patients with RA, PsA,
and AS
 C. Han, D.W. Robinson Jr, M.V. Hackett,
L.C. Paramore, K.H. Fraeman, M.V. Bala.........2167
Echocardiographically Guided Pericardiocentesis
for Treatment of Clinically Significant Pericardial Effusion in RA
 S.A. Cauduro, K.G. Moder, H.S. Luthra,
J.B. Seward .........2173
Posterior Reversible Encephalopathy Syndrome —
An Underrecognized Manifestation of SLE
 J.K. Kur, J.M. Esdaile.........2178
Migraine During SLE: Findings from Brain SPECT
 F. Nobili, A. Mignone, E. Rossi, et al .........2184
The Effect of Menopause on Disease Activity in SLE
 M.B. Urowitz, D. Ibañez, D. Jerome, D.D. Gladman.........2192
Ibuprofen Fails to Prevent Brain Pathology in a
Model of Neuropsychiatric Lupus
 D.A. Ballok,
X. Ma, J.A. Denburg, L. Arsenault, B. Sakic.........2199
Association Between aPL and Recurrent Fetal
Loss in Women Without Autoimmune Disease:
A Metaanalysis
 L. Opatrny, M. David, S.R. Kahn,
I. Shrier, E. Rey.........2214
Postpartum Management of Women at Increased
Risk of Thrombosis — Results of a Canadian
Pilot Survey
 K.A. Spitzer, K. Murphy, M. Crowther,
C.A. Clark, C.A. Laskin.........2222
Autoimmune Disease Aggregation in Families with Primary SS
 J-M. Anaya, G.J. Tobon, P. Vega, J. Castiblanco.........2227
Lower Adrenocortical and Adrenomedullary Responses to Hypoglycemia in Premenopausal Women with SSc
 R. Imrich, J. Lukac, J. Rovensky, et al.........2235
Development and Validation of a Simple Tape-based Measurement Tool for Recording Cervical Rotation in Patients with AS: Comparison with a Goniometer-based Approach
 W.P. Maksymowych, C. Mallon,
R. Richardson, et al .........2242
Membrane Glucocorticoid Receptor Expression on PBMC in Patients with AS
 A.B. Tryc, C.M. Spies, U. Schneider, et al.........2249
Effect of Infliximab Therapy on Employment, Time Lost from Work, and Productivity in Patients
with PsA
 A. Kavanaugh, C. Antoni, P. Mease, et al .........2254
FK506 Inhibits Murine AA Amyloidosis: Possible Involvement of T Cells in Amyloidogenesis
 M. Ueda, Y. Ando, M. Nakamura, et al .........2260
Prevalence of Knee OA in the USA: Arthritis Data from the Third National Health and Nutrition Examination Survey 1991-94
 C.F. Dillon, E.K. Rasch, Q. Gu, R. Hirsch .........2271
Musculoskeletal Findings and Disability in Alkaptonuria
 M.B. Perry, P. Suwannarat,
G.P. Furst, W.A. Gahl, L.H. Gerber.........2280
Is Chronic Pain in Adulthood Related to Childhood Factors? A Population-Based Case-Control Study
of Young Adults
 C.D. Mallen, G. Peat, E. Thomas, P.R. Croft.........2286
The Symptom Intensity Scale, Fibromyalgia, and the Meaning of Fibromyalgia-like Symptoms
 F. Wolfe, J.J. Rasker.........2291
Higher Prevalence of Fibromyalgia in Patients Infected with HTLV-I
 B.A. Cruz, B. Catalan-Soares,
F. Proietti, and The Interdisciplinary HTLV-I/II
Research Group.........2300
Method Guidelines for Cochrane Musculoskeletal Group Systematic Reviews
 L. Maxwell, N. Santesso, P.S. Tugwell,
G.A. Wells, M. Judd, R. Buchbinder, and the Editorial Board
of the Cochrane Musculoskeletal Group.........2304
Knowledge Transfer to Clinicians and Consumers by the Cochrane Musculoskeletal Group
 N. Santesso,
L. Maxwell, P.S. Tugwell, G.A. Wells, A.M. O'Connor,
M. Judd, R. Buchbinder, and the Editorial Board of the
Cochrane Musculoskeletal Group.........2312
Meeting Report Position Development Conference of the International Society for Clinical Densitometry. Vancouver, BC, July 15-17, 2005
 E.S. Leib, N. Binkley, J.P. Bilezikian,
D.L. Kendler, E.M. Lewiecki, S.M. Petak.........2319
Pediatric Rheumatology
Candidate Early Predictors for Progression to Joint Damage in Systemic JIA
 C. Sandborg, T.H. Holmes, T. Lee, et al .........2322
Benefit of Intraarticular Corticosteroid Injection Under Fluoroscopic Guidance for Subtalar Arthritis
in JIA
 T. Beukelman, B. Arabshahi, A.M. Cahill,
R.D. Kaye, R.Q. Cron.........2330
MRI Identifies Features in Clinically Unaffected
Knees Predicting Extension of Arthritis in Children with Monoarthritis
 J.M. Gardner-Medwin, O.G. Killeen,
C.A.J. Ryder, K. Bradshaw, K. Johnson.........2337
Case Reports
Hypertrophic Pachymeningitis in RA After Adalimumab Administration
 M. Ahmed, M. Luggen, J.H. Herman, et al.........2344
Pulmonary Veno-Occlusive Disease and SSc Associated Pulmonary Hypertension
 S.R. Johnson,
D. Patsios, D.M. Hwang, J.T. Granton.........2347
Microscopic Polyangiitis Associated with Primary Biliary Cirrhosis: a Causal or Casual Association?
 L.M. Amezcua-Guerra, P. Prieto, R. Bojalil, C. Pineda,
M-C. Amigo.........2351
Bone Involvement in Generalized Crystal-Storing Histiocytosis
 V. de Lastours, T. Papo, D. Cazals-Hatem, et al .........2354
Correspondence
Should Physicians Manipulate Their Assessment Tools? No, They Shouldn't!
 B.F. Leeb.........2359
Reply
 Y. El Miedany, M. El Gaafary .........2360
TNF-a as a Potential Target in the Treatment of SLE:
A Role for the HMG-CoA Reductase Inhibitor Simvastatin
 P.J. Kotyla, B. Sliwinska-Kotyla,
E.J. Kucharz.........2361
Reply  Y. Shoenfeld.........2363
The Value of Temporal Artery Biopsy Specimen Length in the Diagnosis of GCA
 K. Arashvand .........2363
Reply
 R.M. Taylor-Gjevre.........2364
Can Pain Be Quantified Numerically?
 V.W. Berger.........2364
Reply
 P. Ritter.........2365
RS3PE Syndrome: Followup for Neoplasia
 P. Fietta, P. Manganelli.........2365
Reply
 E. Russell.........2366
Letter
Inclusion of Patients in RCT
 O. Hubscher.........2366
Book Reviews
Osteoarthritis Handbook.........2366
Canadian Residents' Rheumatology Handbook.........2366
Corrections
Seasonal Variations in Onset of Wegener's Granulomatosis: Increased in Summer? Aouba, C. Pagnoux, and
L. Guillevin, for the French Vasculitis Study Group.........2367
Assessing a Whiplash Management Model: A Population-Based Non-Randomized Intervention Study S. Suissa, M. Giroux, M. Gervais, et al .........2367
Meetings in Rheumatology.........
|